Liberty Wealth Management LLC Spero Therapeutics, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$13.09 - $18.77 $26,180 - $37,540	-2,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$12.22 - $15.79 $316,742 - $409,276	-25,920 Reduced 92.84%	2,000 $28,000
Q2 2021 Aug 13, 2021	BUY	$12.22 - $15.79 $316,742 - $409,276	25,920 Added 1296.0%	27,920 $2 Million
Q3 2020 Nov 05, 2020	BUY	$8.96 - $14.12 $17,920 - $28,240	2,000 New	2,000 $22,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.